elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q37412781-16526149-81E3-41F1-B85F-EF61FDBA464E
Q37412781-16526149-81E3-41F1-B85F-EF61FDBA464E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37412781-16526149-81E3-41F1-B85F-EF61FDBA464E
Tofacitinib versus etanercept or placebo in patients with moderate to severe chronic plaque psoriasis: patient-reported outcomes from a Phase 3 study.
P2860
Q37412781-16526149-81E3-41F1-B85F-EF61FDBA464E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37412781-16526149-81E3-41F1-B85F-EF61FDBA464E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
741afe4b53a9feb963c4905ee48ae7bf5d5c3cbf
P2860
Psoriasis has a major secondary impact on the lives of family members and partners.